Laura Marie Gail

Laura Marie Gail

Auto-generated profile, based on publicly available information

Laura Marie Gail

Department of Dermatology, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JSJohanna Strobl
Johanna Strobl
LGLaura Marie Gail
Laura Marie Gail
LKLisa Kleißl
Lisa Kleißl
RPRam Vinay Pandey
Ram Vinay Pandey
VSValerie Smejkal
Valerie Smejkal
GSGeorg Stary
Georg Stary
Emigration of tissue-resident memory T cells (TRMs) was recently introduced in mouse models and may drive systemic inflammation. Skin TRMs of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) can coexist beside donor T cells, offering a unique human model system to study T cell migration. By genotyping, mathematical modeling, single-cell transcriptomics, and functional analysis of patient blood and skin T cells, we detected a small consistent population of circulating skin-derived T cells with a TRM phenotype (cTRMs) in the blood and unveil their skin origin and striking resemblance to skin TRMs. Blood from patients with active graft-versus-host disease (GVHD) contains elevated numbers of host cTRMs producing pro-inflammatory Th2/Th17 cytokines and mediating keratinocyte damage. Expression of gut-homing receptors and the occurrence of cTRMs in gastrointestinal GVHD lesions emphasize their potential to reseed and propagate inflammation in distant organs. Collectively, we describe a distinct circulating T cell population mirroring skin inflammation, which could serve as a biomarker or therapeutic target in GVHD.

23 August 2024 in Science Immunology
Verified
Journal Article
Closed access
PSPhilipp Starkl
Philipp Starkl
GJGustav Jonsson
Gustav Jonsson
TATyler Artner
Tyler Artner
BTBruna Lenfers Turnes
Bruna Lenfers Turnes
LGLaura-Marie Gail
Laura-Marie Gail
SCShane J. F. Cronin
Shane J. F. Cronin
Postoperative pain affects most patients after major surgery and can transition to chronic pain. The considerable side effects and limited efficacy of current treatments underline the need for new therapeutic options. We observed increased amounts of the metabolites BH4 and serotonin after skin injury. Mast cells were primary postoperative sources of Gch1 , the rate-limiting enzyme in BH4 synthesis, itself an obligate cofactor in serotonin production by tryptophan hydroxylase (Tph1). Mice deficient in mast cells or in mast cell–specific Gch1 or Tph1 showed drastically decreased postoperative pain. We found that injury induced the nociceptive neuropeptide substance P, mast cell degranulation, and granule nerve colocalization. Substance P triggered serotonin release in mouse and human mast cells, and substance P receptor blockade substantially ameliorated pain hypersensitivity. Our findings highlight the importance of mast cells at the neuroimmune interface and substance P–driven mast cell BH4 and serotonin production as a therapeutic target for postoperative pain treatment.

27 November 2023 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
JSJohanna Strobl
Johanna Strobl
LGLaura M Gail
Laura M Gail
LKLaura Krecu
Laura Krecu
SMShaista Madad
Shaista Madad
LKLisa Kleißl
Lisa Kleißl
GSGeorg Stary
Georg Stary
Graft-versus-host disease (GvHD) is a major life-threatening complication of allogeneic haematopoietic stem cell transplantation (HSCT), limiting the broad application of HSCT for haematological malignancies. Cutaneous GvHD is described as a post-transplant inflammatory reaction by skin-infiltrating donor T cells and remaining recipient tissue-resident memory T cells. Despite the major influence of lymphocytes on GvHD pathogenesis, the complex role of mononuclear phagocytes (MNPs) in tissues affected by GvHD is increasingly appreciated. To characterize the identity, origin and functions of MNPs in patients with acute cutaneous GvHD. Using single-cell RNA sequencing and multiplex tissue immunofluorescence, we identified an increased abundance of MNPs in skin and blood from 36 patients with acute cutaneous GvHD. In cases of sex-mismatched transplantation, we used expression of X-linked genes to detect rapid tissue adaptation of newly recruited donor MNPs resulting in similar transcriptional states of host- and donor-derived macrophages within GvHD skin lesions. We showed that cutaneous GvHD lesions harbour expanded CD163+ tissue-resident macrophage populations with anti-inflammatory and tissue-remodelling properties including interleukin-10 cytokine production. Cell–cell interaction analyses revealed putative signalling to strengthen regulatory T-cell responses. Notably, macrophage polarization in chronic cutaneous GvHD types was proinflammatory and drastically differed from acute GvHD, supporting the notion of distinct cellular players in different clinical GvHD subtypes. Overall, our data reveal a surprisingly dynamic role of MNPs after HSCT. Specific and time-resolved targeting to repolarize this cell subset may present a promising therapeutic strategy in combatting GvHD skin inflammation.

12 October 2022 in Leukemia
Verified
Journal Article
Closed access
PDF file
NBNadine Bayer
Nadine Bayer
BHBela Hausmann
Bela Hausmann
RPRam Vinay Pandey
Ram Vinay Pandey
FDFlorian Deckert
Florian Deckert
LGLaura-Marie Gail
Laura-Marie Gail
GSGeorg Stary
Georg Stary

28 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJohanna Strobl
Johanna Strobl
LKLisa Kleißl
Lisa Kleißl
JEJulia Eder
Julia Eder
SCSally Connolly
Sally Connolly
TFTobias Frey
Tobias Frey
GSGeorg Stary
Georg Stary
Arthropods are ancient vectors of infectious disease that alter the immune environment of the skin during feeding. The epidermis and its immune sentinels, including Langerhans cells, are critical for protection against ectoparasitic arthropods such as ticks. Here, we investigate how human Langerhans cells respond to clinical and experimental tick bites and concomitant infection with the tick-borne bacterium Borrelia burgdorferi. Using imaging, migration assays, immune spheroid models, and single-cell transcriptomic analysis of patient samples, we show that tick bites and tick saliva reprogram Langerhans cells to increase migration into lymphatic tissues, adopt a tolerogenic state marked by specific transcriptional programs, reduced ability to induce pro-inflammatory helper T cells, and enhanced promotion of type 2 and regulatory T cell responses. This shift dampens protective immunity and helps explain how ticks and their pathogens evade host defense and achieve efficient transmission.

27 April 2026 in Chemical Science
Verified
Journal Article
Open access
PDF file
ISIakovos Saridakis
Iakovos Saridakis
MSManuel Schupp
Manuel Schupp
HZHaoqi Zhang
Haoqi Zhang
TLThomas Leischner
Thomas Leischner
LGLaura Marie Gail
Laura Marie Gail
NMNuno Maulide
Nuno Maulide
The macrocyclic immunosuppressive natural product (−)-FR252921 was isolated in 2003 from a liquid culture of Pseudomonas fluorescens. Despite promising preliminary immunological insights, in-depth studies that advance our understanding of structure–activity relationship (SAR) have been scarce. Herein we document a detailed SAR mapping of (−)-FR252921 by the syntheses of 14 analogs and their subsequent evaluation. The composed library of analogs was designed to address crucial questions regarding the roles of explicit molecular features of the natural product while following a target-agnostic efficacy approach. Whereas previous efforts have focused on murine T cell assays, our endeavors transit to a primary human cell-based immunological platform using peripheral blood mononuclear cells (PBMCs), enabling direct assessment of immunosuppressive activity in B, natural killer (NK), and T cells via cytokine suppression. We emphasize that a new fully synthetic (−)-FR252921 analog (fs-FR4) profoundly outperformed the natural product in suppressing the response of both stimulated B cells (21-fold) and NK cells (16-fold) within the context the biological assays used, validating the power of our platform and standing as a lead candidate for further preclinical development. Lastly, we highlight that our studies included significant improvement in the synthetic efficacy of previously reported building blocks and key synthetic steps towards (−)-FR252921 and analogs.